CU
Christian Uhrich
Investments at M Ventures
Karlsruhe, Baden-Württemberg
Overview
Christian Uhrich is an Investment Director specializing in Biotechnology Investments at M Ventures, with a strong background in venture capital and entrepreneurship. He holds a leadership position overseeing investment strategies and has served on multiple boards of directors within the biotech industry.
Uhrich's career highlights include his role as Head of Strategy at M Ventures and his involvement on the boards of LabGenius, Indi Molecular, and other biotech companies, showcasing his expertise in business development and strategic decision-making in the field of biotechnology investments.
Work Experience
Investment Director, Biotechnology Investments
2021 - Current
Head of Strategy
2019 - 2021
Board Observer
2024
Member Board of Directors
2023
Indi Molecular is an emerging life sciences company that is developing a synthetic class of diagnostic and therapeutic.
Raised $13,300,000.00 from M Ventures, SABEY, Legend Capital and Asset Management Ventures (AMV).
Member Board of Directors
2023
Board Observer
2023
Member Board of Directors
2022
Member Board of Directors
2022
Board Observer
2022
Board Observer
2022
Member Board of Directors
2021 - 2022
Riffyn was acquired by Siemens and integrated into the Siemens Life Science offerings as Riffyn X in 2022.